The prognostic significance of trisomy 8 in patients with acute myeloid leukemia

Michelle A. Elliott, Louis Letendre, Curtis A. Hanson, Ayalew Tefferi, Gordon W. Dewald

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Recent therapeutic outcomes for patients with acute myeloid leukemia and trisomy 8 (+8) who were seen at our institution were investigated. Complete remission was achieved in 85% with isolated +8, 100% with +8 and chromosomal abnormalities predictive of a favorable outcome, and 47% of patients with +8 and other, mostly complex chromosomal abnormalities. Median relapse-free and overall survivals in months were 5.5 and 12 (isolated +8), 20 and 25 (+8 and favorable karyotype), and 7.5 and 6 (+8 and unfavorable karyotype). Despite an encouraging rate of complete remission, the relapse-free and overall survivals for patients with isolated +8 were not significantly different from those of patients with +8 and unfavorable karyotypes. The presence of +8 did not appear to adversely affect the outcome of patients with favorable karyotypes.

Original languageEnglish (US)
Pages (from-to)583-586
Number of pages4
JournalLeukemia and Lymphoma
Volume43
Issue number3
DOIs
StatePublished - 2002

Fingerprint

Acute Myeloid Leukemia
Karyotype
Chromosome Aberrations
Recurrence
Survival
Trisomy Chromosome 8
Therapeutics

Keywords

  • Leukemia
  • Myeloid
  • Treatment outcome
  • Trisomy 8

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

The prognostic significance of trisomy 8 in patients with acute myeloid leukemia. / Elliott, Michelle A.; Letendre, Louis; Hanson, Curtis A.; Tefferi, Ayalew; Dewald, Gordon W.

In: Leukemia and Lymphoma, Vol. 43, No. 3, 2002, p. 583-586.

Research output: Contribution to journalArticle

Elliott, Michelle A. ; Letendre, Louis ; Hanson, Curtis A. ; Tefferi, Ayalew ; Dewald, Gordon W. / The prognostic significance of trisomy 8 in patients with acute myeloid leukemia. In: Leukemia and Lymphoma. 2002 ; Vol. 43, No. 3. pp. 583-586.
@article{4fc17fdd416b4e6cb6fa906eec9288ab,
title = "The prognostic significance of trisomy 8 in patients with acute myeloid leukemia",
abstract = "Recent therapeutic outcomes for patients with acute myeloid leukemia and trisomy 8 (+8) who were seen at our institution were investigated. Complete remission was achieved in 85{\%} with isolated +8, 100{\%} with +8 and chromosomal abnormalities predictive of a favorable outcome, and 47{\%} of patients with +8 and other, mostly complex chromosomal abnormalities. Median relapse-free and overall survivals in months were 5.5 and 12 (isolated +8), 20 and 25 (+8 and favorable karyotype), and 7.5 and 6 (+8 and unfavorable karyotype). Despite an encouraging rate of complete remission, the relapse-free and overall survivals for patients with isolated +8 were not significantly different from those of patients with +8 and unfavorable karyotypes. The presence of +8 did not appear to adversely affect the outcome of patients with favorable karyotypes.",
keywords = "Leukemia, Myeloid, Treatment outcome, Trisomy 8",
author = "Elliott, {Michelle A.} and Louis Letendre and Hanson, {Curtis A.} and Ayalew Tefferi and Dewald, {Gordon W.}",
year = "2002",
doi = "10.1080/10428190290012074",
language = "English (US)",
volume = "43",
pages = "583--586",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - The prognostic significance of trisomy 8 in patients with acute myeloid leukemia

AU - Elliott, Michelle A.

AU - Letendre, Louis

AU - Hanson, Curtis A.

AU - Tefferi, Ayalew

AU - Dewald, Gordon W.

PY - 2002

Y1 - 2002

N2 - Recent therapeutic outcomes for patients with acute myeloid leukemia and trisomy 8 (+8) who were seen at our institution were investigated. Complete remission was achieved in 85% with isolated +8, 100% with +8 and chromosomal abnormalities predictive of a favorable outcome, and 47% of patients with +8 and other, mostly complex chromosomal abnormalities. Median relapse-free and overall survivals in months were 5.5 and 12 (isolated +8), 20 and 25 (+8 and favorable karyotype), and 7.5 and 6 (+8 and unfavorable karyotype). Despite an encouraging rate of complete remission, the relapse-free and overall survivals for patients with isolated +8 were not significantly different from those of patients with +8 and unfavorable karyotypes. The presence of +8 did not appear to adversely affect the outcome of patients with favorable karyotypes.

AB - Recent therapeutic outcomes for patients with acute myeloid leukemia and trisomy 8 (+8) who were seen at our institution were investigated. Complete remission was achieved in 85% with isolated +8, 100% with +8 and chromosomal abnormalities predictive of a favorable outcome, and 47% of patients with +8 and other, mostly complex chromosomal abnormalities. Median relapse-free and overall survivals in months were 5.5 and 12 (isolated +8), 20 and 25 (+8 and favorable karyotype), and 7.5 and 6 (+8 and unfavorable karyotype). Despite an encouraging rate of complete remission, the relapse-free and overall survivals for patients with isolated +8 were not significantly different from those of patients with +8 and unfavorable karyotypes. The presence of +8 did not appear to adversely affect the outcome of patients with favorable karyotypes.

KW - Leukemia

KW - Myeloid

KW - Treatment outcome

KW - Trisomy 8

UR - http://www.scopus.com/inward/record.url?scp=0036125350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036125350&partnerID=8YFLogxK

U2 - 10.1080/10428190290012074

DO - 10.1080/10428190290012074

M3 - Article

C2 - 12002762

AN - SCOPUS:0036125350

VL - 43

SP - 583

EP - 586

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 3

ER -